ZhuZhou QianJin Pharmaceutical Co Ltd Asset Resilience Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd asset resilience ratio. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has an Asset Resilience Ratio of 0.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ZhuZhou QianJin Pharmaceutical Co Ltd (600479) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)
Asset resilience ratio of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how ZhuZhou QianJin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read ZhuZhou QianJin Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down ZhuZhou QianJin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of ZhuZhou QianJin Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.55 Million | 0.03% |
| Total Liquid Assets | CN¥1.55 Million | 0.03% |
Asset Resilience Insights
- Limited Liquidity: ZhuZhou QianJin Pharmaceutical Co Ltd maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ZhuZhou QianJin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare ZhuZhou QianJin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
ZhuZhou QianJin Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2001–2025)
ZhuZhou QianJin Pharmaceutical Co Ltd asset resilience ratio by year from 2001 to 2025. The table below shows the annual Asset Resilience Ratio data for ZhuZhou QianJin Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.04% | CN¥1.94 Million ≈ $283.18K |
CN¥4.96 Billion ≈ $726.34 Million |
-0.07pp |
| 2024-12-31 | 0.10% | CN¥4.76 Million ≈ $697.02K |
CN¥4.56 Billion ≈ $666.73 Million |
-10.53pp |
| 2022-12-31 | 10.64% | CN¥491.74 Million ≈ $71.96 Million |
CN¥4.62 Billion ≈ $676.34 Million |
-7.51pp |
| 2021-12-31 | 18.15% | CN¥736.84 Million ≈ $107.82 Million |
CN¥4.06 Billion ≈ $594.14 Million |
+2.72pp |
| 2020-12-31 | 15.42% | CN¥652.25 Million ≈ $95.44 Million |
CN¥4.23 Billion ≈ $618.79 Million |
+12.28pp |
| 2018-12-31 | 3.14% | CN¥109.05 Million ≈ $15.96 Million |
CN¥3.47 Billion ≈ $508.13 Million |
-2.40pp |
| 2017-12-31 | 5.54% | CN¥182.19 Million ≈ $26.66 Million |
CN¥3.29 Billion ≈ $480.97 Million |
+5.29pp |
| 2016-12-31 | 0.26% | CN¥7.76 Million ≈ $1.14 Million |
CN¥3.03 Billion ≈ $443.69 Million |
-0.88pp |
| 2015-12-31 | 1.13% | CN¥31.09 Million ≈ $4.55 Million |
CN¥2.74 Billion ≈ $401.42 Million |
-1.99pp |
| 2014-12-31 | 3.12% | CN¥69.56 Million ≈ $10.18 Million |
CN¥2.23 Billion ≈ $326.16 Million |
+1.95pp |
| 2013-12-31 | 1.17% | CN¥22.12 Million ≈ $3.24 Million |
CN¥1.89 Billion ≈ $276.32 Million |
-4.45pp |
| 2012-12-31 | 5.62% | CN¥92.52 Million ≈ $13.54 Million |
CN¥1.65 Billion ≈ $240.75 Million |
-2.06pp |
| 2011-12-31 | 7.69% | CN¥98.53 Million ≈ $14.42 Million |
CN¥1.28 Billion ≈ $187.55 Million |
+2.35pp |
| 2010-12-31 | 5.34% | CN¥60.27 Million ≈ $8.82 Million |
CN¥1.13 Billion ≈ $165.13 Million |
-12.99pp |
| 2009-12-31 | 18.33% | CN¥231.98 Million ≈ $33.95 Million |
CN¥1.27 Billion ≈ $185.22 Million |
+18.31pp |
| 2008-12-31 | 0.02% | CN¥176.50K ≈ $25.83K |
CN¥1.06 Billion ≈ $155.02 Million |
-11.96pp |
| 2007-12-31 | 11.98% | CN¥130.01 Million ≈ $19.02 Million |
CN¥1.09 Billion ≈ $158.81 Million |
+7.76pp |
| 2006-12-31 | 4.22% | CN¥34.99 Million ≈ $5.12 Million |
CN¥828.73 Million ≈ $121.27 Million |
+3.47pp |
| 2005-12-31 | 0.75% | CN¥6.03 Million ≈ $881.81K |
CN¥798.23 Million ≈ $116.81 Million |
-0.01pp |
| 2004-12-31 | 0.77% | CN¥6.09 Million ≈ $890.72K |
CN¥792.53 Million ≈ $115.97 Million |
+0.72pp |
| 2001-12-31 | 0.05% | CN¥172.00K ≈ $25.17K |
CN¥332.78 Million ≈ $48.70 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more